Sweet's Syndrome Associated with Cerebrospinal Fluid Neutrophilic Pleocytosis

Martínez, Eduardo; Fernández, A; Mayo, José; Manrique, Pilar; Collazos, Julio

doi:10.1111/j.1365-4362.1995.tb04389.x

Cited by 18 publications

(5 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Extracutaneous manifestations of Sweet's syndrome can affect not only the mucosa of the eyes and mouth, but also the bone, central nervous system, kidneys, intestines, liver, heart, bronchi and lungs, muscles, and spleen (Table 3). 6,7,9,11,16,18,24,25,28,36,52,68,69,75,85,97–129 Involvement of the oral mucosa most commonly presents as ulcers in Sweet's syndrome patients with hematologic disorders 14,18 ,69,75 ,115,127 . Similar to extracutaneous manifestations of Sweet's syndrome at other sites, the oral lesions typically resolve after the initiation of treatment with systemic corticosteroids.…”

Section: Clinical Characteristicsmentioning

confidence: 99%

Sweet's syndrome revisited: a review of disease concepts

2003

View full text Add to dashboard Cite

Sweet's syndrome, also referred to as acute febrile neutrophilic dermatosis, is characterized by a constellation of symptoms and findings: fever, neutrophilia, erythematous and tender skin lesions that typically show an upper dermal infiltrate of mature neutrophils, and prompt improvement of both symptoms and lesions after the initiation of treatment with systemic corticosteroids. Hundreds of patients with this dermatosis have been reported. The manifestations of Sweet's syndrome in these individuals have not only confirmed those originally described by Dr Robert Douglas Sweet in 1964, but have also introduced new features that have expanded the clinical and pathologic concepts of this condition. The history, clinical characteristics, laboratory findings, associated diseases, pathology, and treatment options of Sweet's syndrome are reviewed. The evolving and new concepts of this dermatosis that are discussed include: (i) Sweet's syndrome occurring in the clinical setting of a disease-related malignancy, or medication, or both; (ii) detection of additional sites of extracutaneous Sweet's syndrome manifestations; (iii) discovery of additional Sweet's syndrome-associated diseases; (iv) variability of the composition and/or location of the cutaneous inflammatory infiltrate in Sweet's syndrome lesions; and (v) additional efficacious treatments for Sweet's syndrome.

show abstract

Section: Clinical Characteristicsmentioning

confidence: 99%

Sweet's syndrome revisited: a review of disease concepts

2003

View full text Add to dashboard Cite

show abstract

“…[7][8][9] A transient increase of neutrophils in CSF samples was reported in neonatal and adult patients with Sweet syndrome. [13][14][15] Yoshiura et al 8 reported a case of Sweet syndrome with disturbances of intelligence and eye movement. Lesions were demonstrated in the basal ganglia and brainstem on MRIs (in abstract form).…”

Section: Commentmentioning

confidence: 99%

"Neuro-Sweet Disease"

Hisanaga¹,

Hosokawa²,

Sato³

et al. 1999

Arch Neurol

View full text Add to dashboard Cite

show abstract

“…To the best of our knowledge, 22 cases of Sweet's syndrome associated with CNS involvement have been reported in the English and Japanese literature, 4–23 including the present case. The mean age is 47.6 years ( n = 22) and the sex distribution (male : female) is 12 : 10 ( n = 22) (Table 1).…”

Section: Discussionmentioning

confidence: 69%